SYRS - Syros Pharmaceuticals EPS beats by $0.24 beats on revenue May, 06 2021 07:33 AM Syros Pharmaceuticals Inc. Syros Pharmaceuticals (SYRS): Q1 GAAP EPS of -$0.23 beats by $0.24.Revenue of $4.83M (+102.9% Y/Y) beats by $2.16M.Shares +2.55% PM.Press Release For further details see: Syros Pharmaceuticals EPS beats by $0.24, beats on revenue